A carregar...

Clinical implications of PTEN loss in prostate cancer

Genomic aberrations of the PTEN tumour suppressor gene are among the most common in prostate cancer. Inactivation of the PTEN gene by deletion or mutation is identified in ~20% of primary prostate tumour samples at radical prostatectomy and as many as 50% of castration resistant tumours. Loss of PTE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nat Rev Urol
Main Authors: Jamaspishvili, Tamara, Berman, David M., Ross, Ashley E., Scher, Howard I., De Marzo, Angelo M., Squire, Jeremy A., Lotan, Tamara L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7472658/
https://ncbi.nlm.nih.gov/pubmed/29460925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrurol.2018.9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!